MedPath

Starclav

Brand Name: Starclav

Generic Name: Co-Amoxiclav

Active
Registration Number

DRP-7169

Dosage Form

Powder For Injection (I.V)

Issuance Date

March 1, 2024

Expiry Date

March 30, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1g/200mg
PackagingUSP Type III Clear Glass Vial x 20mL (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Co-AmoxiclavActive
Monograph: co-amoxiclav

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform